# ERLOTINIB

NDC: 31722-263
Generic name: ERLOTINIB
Labeler / Manufacturer: Camber Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20240524

FDA application: ANDA209267

## Active ingredients

- ERLOTINIB HYDROCHLORIDE: 25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"31722-263"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=31722-263
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a3b2d622-b4d5-4819-862b-f8fd3adcec6f